FDA inspection
Osteolife Biomedical I LLC: FDA inspection ending Feb 4, 2022
FDA inspection 1161595 · Official Action Indicated (OAI) · Miami, FL
Key facts
| Inspection ID | 1161595 |
|---|---|
| Firm | Osteolife Biomedical I LLC |
| FEI number | 3014623896 |
| Address | 1951 Nw 7th Ave Sanibel Suite |
| City | Miami |
| State | FL |
| ZIP | 33136 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Feb 4, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
| Warning letter | 626889 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data